PDCD1 and Miyoshi myopathy: According to the reported findings Bor treatment was able to sustain the activation of T cell-mediated immune responses in MM-bearing mice, associated with a reduction of the inhibitory marker PD-1 and an increased expression of the anticancer cytokine IFN-γ.